Susquehanna International Group’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.9K | Sell |
96,909
-134,541
| -58% | -$51.3K | ﹤0.01% | 6076 |
|
|
2025
Q1 | $221K | Buy |
231,450
+29,438
| +15% | +$28.1K | ﹤0.01% | 5416 |
|
|
2024
Q4 | $366K | Buy |
202,012
+138,843
| +220% | +$251K | ﹤0.01% | 4489 |
|
|
2024
Q3 | $91K | Buy |
63,169
+22,157
| +54% | +$31.9K | ﹤0.01% | 5147 |
|
|
2024
Q2 | $52.5K | Sell |
41,012
-201,655
| -83% | -$258K | ﹤0.01% | 5267 |
|
|
2024
Q1 | $917K | Buy |
242,667
+36,955
| +18% | +$140K | ﹤0.01% | 2753 |
|
|
2023
Q4 | $1.06M | Buy |
+205,712
| New | +$1.06M | ﹤0.01% | 2794 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6249 |
|
|
2023
Q2 | – | Sell |
-73,108
| Closed | -$306K | – | 6353 |
|
|
2023
Q1 | $306K | Sell |
73,108
-18,422
| -20% | -$77.2K | ﹤0.01% | 4393 |
|
|
2022
Q4 | $389K | Buy |
91,530
+19,312
| +27% | +$82.1K | ﹤0.01% | 3544 |
|
|
2022
Q3 | $115K | Buy |
+72,218
| New | +$115K | ﹤0.01% | 5197 |
|
|
2022
Q2 | – | Sell |
-31,303
| Closed | -$77K | – | 6555 |
|
|
2022
Q1 | $77K | Buy |
31,303
+2,930
| +10% | +$7.21K | ﹤0.01% | 5207 |
|
|
2021
Q4 | $80K | Buy |
28,373
+1,738
| +7% | +$4.9K | ﹤0.01% | 5355 |
|
|
2021
Q3 | $108K | Buy |
+26,635
| New | +$108K | ﹤0.01% | 4958 |
|